Clover Health Investments, Corp.

NASDAQ:CLOV

Medical - Healthcare Plans

Healthcare
$4.17 +3.54%

+$0.17 today

Market cap
$2.21B
Beta
2.48
P/E (TTM)
-45.6
EPS (TTM)
-$0.11
52W Low $1.58High $5.18

Volume 8.05M

Average 7.31M

CLOV Common Stock Issued

Cash raised by issuing new shares.

Clover Health Investments, Corp.NASDAQ: CLOV

Common Stock Issued · Q2 FY2026 · quarter ended Jun 2026

Common stock issued growth accelerates

Q2 FY2026 common stock issued of $1.65M rose 135.0% year over year, ahead of the +43.5% change in trailing-twelve-month common stock issued. Sequentially, it rose 5406.7% from the prior quarter. Over 3 fiscal years it compounded at +9.0% a year.

Context

  • Common stock issued amounted to 0.1% of revenue in FY2025, unchanged from a year earlier.
  • Common stock issued increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +135.0% holds above the trailing-twelve-month pace of +43.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.65M+5406.7% QoQ
Last fiscal yearDec 2025
$1.81M+101.1% YoY
LTMJun 2026
$2.58M+43.5% YoY
Common Stock Issued past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+135.0%——
1 year+101.1%——
3-year CAGR+9.0%——
5-year CAGR——
10-year CAGR——

Common Stock Issued history

USD · from the cash flow

Latest · FY2025
1.81M USD
Year-over-year change
+101.1%
4-year CAGR
-71.9%

Common Stock Issued vs competitors

How CLOV compares with its peers on the latest reported figures

  • CLOV's LTM Jun 2026 common stock issued of $2.58M is the 6th largest of the 7 companies compared; the peer median is $31.37M.
  • Its year-over-year change of +43.5% is the 3rd highest of 6, against a peer median of +8.0%.
  • Common stock issued amounts to 0.1% of revenue for CLOV, versus a peer median of 0.1%.
CLOV Competitors Peer median
Common Stock Issued for CLOV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CVSCVS Health CorporationLTM Jun 2026$420M +793.6%—0.1%
CICigna CorporationLTM Sep 2026$216M +8.0%-19.5%0.1%
CNCCentene CorporationLTM Jun 2026$37M -5.1%-19.1%0.0%
OSCROscar Health, Inc.LTM Jun 2026$25.74M -50.2%+248.6%0.2%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$20.03M +9577.8%—0.5%
CLOVClover Health Investments, Corp.LTM Jun 2026$2.58M +43.5%+9.0%0.1%
HUMHumana Inc.LTM Sep 2026$0 ——0.0%
Peer median (excluding CLOV) $31.37M+8.0%-19.1%0.1%

Competitors are the stored peer set for CLOV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(587.76M)(339.57M)(213.36M)(43.01M)(85.55M)
Depreciation & Amortization1.25M1.19M2.51M1.33M1.69M
Deferred Income Tax(66.09M)0000
Stock-Based Compensation163.72M164.31M140.93M114.33M103.66M
Change in Working Capital192.67M(2.36M)(55.43M)12.86M(84.2M)
Accounts Receivables(9.39M)(8.03M)0(6.55M)(65.95M)
Inventory9.39M0000
Accounts Payables5.31M7.64M4.74M(2.62M)1.65M
Other Working Capital187.37M(1.97M)(60.17M)22.03M(19.9M)
Other Non-Cash Items13.88M(27.49M)9.48M(50.66M)(2.53M)
Operating Cash Flow(282.33M)(203.93M)(115.87M)34.85M(66.93M)
Capital Expenditures(723K)(4.47M)(584K)(1.56M)(2.04M)
Acquisitions (Net)434.72M(16.2M)000
Purchases of Investments(876.25M)(369.65M)(175.57M)(201.24M)(205.1M)
Sales of Investments441.53M485.45M316.16M203.36M211.22M
Other Investing Activities(434.72M)0000
Investing Cash Flow(435.45M)95.13M140.01M565K4.08M
Debt Repayment(30.93M)0000
Common Stock Issued289.92M1.4M1.15M902K1.81M
Common Stock Repurchased(147K)(6.36M)(6.22M)(18.26M)(55.2M)
Dividends Paid00000
Other Financing Activities666.55M0(28.79M)00
Financing Cash Flow925.39M(4.96M)(33.86M)(17.36M)(53.38M)
Effect of Forex Changes00000
Net Change in Cash207.62M(113.76M)(9.72M)18.05M(116.24M)
Free Cash Flow(283.05M)(208.39M)(116.46M)33.29M(68.98M)

Clover Health Investments, Corp.

NASDAQ:CLOV

Intrinsic Alpha fair value

Locked

Current Price

$4.17

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.